ADAM15 to α5β1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis

ADAM15, a member of the A Disintegrin And Metalloproteinase (ADAM) family, is a membrane protein containing an adhesion domain that binds to α5β1 integrin through a unique RGD domain. ADAM15, expressed by human normal colonocytes, is involved in epithelial wound healing and tissue remodeling in inflammatory bowel disease. The aims of our study were (i) to analyze ADAM15 expression in a series of colon carcinomas and paired normal mucosa and (ii) to integrate the spatial relationship of ADAM15 with its binding partners α5β1 integrin, a mesenchymal marker, as well as with other adhesion molecules, α3β1 integrin and E‐cadherin. A series of 94 colon carcinomas of the non other specified category were graded according to the World Health Organization classification. Immunohistochemistry was performed on frozen tissue sections using antibodies directed to ADAM15, α5β1 and α3β1 integrins, and E‐cadherin. ADAM15 was quantified at the mRNA level. Finally, promoter methylation of ADAM15 was examined as well as the microsatellite instability status (MSS/MSI). Thirty‐six percent of colorectal carcinomas displayed a reduced expression of ADAM15 in cancer cells, confirmed at the mRNA level in most cases, without promoter methylation. ADAM15 down‐regulation was associated with histologically poorly differentiated carcinomas. In addition, it was associated with the acquisition of α5β1 by cancer cells and down‐regulation of α3β1 integrin and E‐cadherin. Finally this profile that includes characteristic of epithelial to mesenchymal transition is a late progression event of colon cancer with a poor prognosis.

[1]  R. Dummer,et al.  ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma. , 2010, Biochemical and biophysical research communications.

[2]  K. Saksela,et al.  Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins , 2009, Journal of cellular biochemistry.

[3]  M. Duffy,et al.  Role of ADAMs in Cancer Formation and Progression , 2009, Clinical Cancer Research.

[4]  A. Tolcher,et al.  Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study , 2008, Clinical Cancer Research.

[5]  G. Berx,et al.  Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front , 2008, Histochemistry and Cell Biology.

[6]  P. Howarth,et al.  Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells. , 2008, The Journal of allergy and clinical immunology.

[7]  Didier Merlin,et al.  ADAM‐15: a metalloprotease that mediates inflammation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  M. Day,et al.  ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. , 2008, Cancer research.

[9]  A. Huovila,et al.  ADAM15 gene structure and differential alternative exon use in human tissues , 2007, BMC Molecular Biology.

[10]  L. Terracciano,et al.  Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer , 2007, The Journal of pathology.

[11]  C. Stanners,et al.  A co‐clustering model involving α5β1 integrin for the biological effects of GPI‐anchored human carcinoembryonic antigen (CEA) , 2007 .

[12]  Y. Okada,et al.  ADAMs in cancer cell proliferation and progression , 2007, Cancer science.

[13]  Kenoki Ohuchida,et al.  Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. , 2007, Anticancer research.

[14]  M. Denis,et al.  ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease , 2006, Laboratory Investigation.

[15]  S. Varambally,et al.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. , 2006, Neoplasia.

[16]  H. Spring,et al.  Tumor cell invasiveness correlates with changes in integrin expression and localization , 2005, Oncogene.

[17]  Yutao Yan,et al.  ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[18]  P. Parker,et al.  Integrin-specific signaling pathways controlling focal adhesion formation and cell migration , 2003, The Journal of cell biology.

[19]  A. Duval,et al.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.

[20]  A. Gaultier,et al.  ADAM13 Disintegrin and Cysteine-rich Domains Bind to the Second Heparin-binding Domain of Fibronectin* , 2002, The Journal of Biological Chemistry.

[21]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Kathleen R. Cho,et al.  Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. , 2001, The American journal of pathology.

[23]  V. Yajnik,et al.  Pathology and genetics of tumors of the digestive system , 2001 .

[24]  A. Rashid,et al.  Histopathological identification of colon cancer with microsatellite instability. , 2001, The American journal of pathology.

[25]  J. Kreidberg.  Functions of α3β1 integrin , 2000 .

[26]  P. Slocombe,et al.  Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells. , 1999, Journal of cell science.

[27]  R. Black,et al.  ADAMs: focus on the protease domain. , 1998, Current opinion in cell biology.

[28]  A. Blum,et al.  Differential expression of laminin‐5 subunits and integrin receptors in human colorectal neoplasia , 1998, The Journal of pathology.

[29]  L. Lum,et al.  Metargidin, a Membrane-anchored Metalloprotease-Disintegrin Protein with an RGD Integrin Binding Sequence (*) , 1996, The Journal of Biological Chemistry.

[30]  John Calvin Reed,et al.  The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Wolfsberg,et al.  ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. , 1995, Developmental biology.

[32]  J. Spencer,et al.  E-cadherin expression in intestinal epithelium. , 1995, Journal of clinical pathology.

[33]  G. Weskamp,et al.  A family of cellular proteins related to snake venom disintegrins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Riecken,et al.  Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. , 1992, Gut.

[35]  D. Mason,et al.  The labeled antigen method of immunoenzymatic staining. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  S. Ogino,et al.  Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.

[37]  C. Stanners,et al.  A co-clustering model involving alpha5beta1 integrin for the biological effects of GPI-anchored human carcinoembryonic antigen (CEA). , 2007, Journal of cellular physiology.

[38]  A. Roessner,et al.  The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. , 2005, International journal of oncology.

[39]  Daiya Takai,et al.  The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..

[40]  J. Willson,et al.  Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  Luzhe Sun,et al.  Role of α5β1 integrin in determining malignant properties of colon carcinoma cells , 1997 .

[42]  S. Santoro,et al.  Immunolocalization of alpha-integrin subunits and extracellular matrix components during human colonic organogenesis. , 1996, Gastroenterology.